Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 3776 - 3800 of 6046 in total
Sub Class LM ID Name ▼ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Simple Glc series LMSP05010041
  • Dracontioside B
  • N-(2R-hydroxytetracosanoyl)-1-beta-glucosyl-4R-hydroxy-8Z-octadecasphingenine
9832502 843.679949 C48H93NO10
Simple Glc series LMSP05010040
  • Dracontioside A
  • N-(2R-hydroxyoctadecanoyl)-1-beta-glucosyl-4E,8Z-octadecasphingadienine
134812535 741.575484 C42H79NO9
LMSL02000002
  • Dodecanoyl-Kdo2-Lipid IVA
  • Lauroyl-Kdo2-Lipid IVA
9776848 2027.137644 C96H176N2O38P2
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR08
  • Cytolipin R(d18:1/26:1(17Z))
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261579 1364.890793 C70H128N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR06
  • Cytolipin R(d18:1/26:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261577 1366.906443 C70H130N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR07
  • Cytolipin R(d18:1/24:1(15Z))
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261578 1336.859493 C68H124N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR05
  • Cytolipin R(d18:1/24:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261576 1338.875143 C68H126N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR04
  • Cytolipin R(d18:1/22:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261575 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR03
  • Cytolipin R(d18:1/20:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261574 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR02
  • Cytolipin R(d18:1/18:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261573 1254.781243 C62H114N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR01
  • Cytolipin R(d18:1/16:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261572 1226.749943 C60H110N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR00
  • Cytolipin R
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer
GSG1155
Simple Glc series LMSP05010129
  • Crispin B
  • N-(2R-hydroxy-7Z-pentadecenoyl)-(6-O-(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl)-1-alpha-glucosyl-4E-nonadecasphingenine
171119969 903.607179 C51H85NO12
Simple Glc series LMSP05010128
  • Crispin A
  • N-(2R-hydroxy-7Z-pentadecenoyl)-1-alpha-glucosyl-4E-nonadecasphingenine
171119968 713.544184 C40H75NO9
Simple Glc series LMSP05010109
  • Cortenuamide C
  • N-(2R-hydroxy-docosanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
45272231 811.653734 C47H89NO9
Simple Glc series LMSP05010110
  • Cortenuamide B
  • N-(2R-hydroxy-tricosanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
171119946 825.669384 C48H91NO9
Simple Glc series LMSP05010111
  • Cortenuamide A
  • N-(2R-hydroxy-tetracosanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
171119945 839.685034 C49H93NO9
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG08
  • ClcNAc-Lex-5(d18:1/26:1(17Z))
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261443 1714.028077 C84H151N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG06
  • ClcNAc-Lex-5(d18:1/26:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261441 1716.043727 C84H153N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG07
  • ClcNAc-Lex-5(d18:1/24:1(15Z))
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261442 1685.996777 C82H147N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG05
  • ClcNAc-Lex-5(d18:1/24:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261440 1688.012427 C82H149N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG04
  • ClcNAc-Lex-5(d18:1/22:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261439 1659.981127 C80H145N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG03
  • ClcNAc-Lex-5(d18:1/20:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261438 1631.949827 C78H141N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG02
  • ClcNAc-Lex-5(d18:1/18:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261437 1603.918527 C76H137N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG01
  • ClcNAc-Lex-5(d18:1/16:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261436 1575.887227 C74H133N3O32

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024